Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes

Type 2 diabetes (T2D) is a progressive disease affecting glucose regulation and a major cause of morbidity and mortality globally. Many patients are not escalated up the treatment ladder appropriately despite failing to achieve glycemic control, with barriers such as fear of hypoglycemia, weight gai...

Descripción completa

Detalles Bibliográficos
Autores principales: Valentine, Virginia, Goldman, Jennifer, Shubrook, Jay H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544623/
https://www.ncbi.nlm.nih.gov/pubmed/28721686
http://dx.doi.org/10.1007/s13300-017-0287-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544623/
https://www.ncbi.nlm.nih.gov/pubmed/28721686
http://dx.doi.org/10.1007/s13300-017-0287-y

Ejemplares similares